O'Shaughnessy Asset Management, LLC Vericel Corp Transaction History

O'Shaughnessy Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $116,864 - $174,632	-3,320 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$46.35 - $59.75 $125,330 - $161,564	-2,704 Reduced 44.89%	3,320 $162,000
Q2 2021 Aug 09, 2021	SELL	$47.2 - $67.81 $204,942 - $294,431	-4,342 Reduced 41.89%	6,024 $316,000
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $223,592 - $429,980	-7,229 Reduced 41.09%	10,366 $575,000
Q4 2020 Feb 11, 2021	BUY	$18.53 - $31.5 $325,572 - $553,455	17,570 Added 70280.0%	17,595 $543,000
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $212 - $395	25 New	25 $0
Q1 2020 May 13, 2020	SELL	$7.25 - $19.22 $449 - $1,191	-62 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$13.77 - $19.2 $853 - $1,190	62 New	62 $1,000

293

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.26B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.